Hrt Financial LP Organogenesis Holdings Inc. Transaction History

Hrt Financial LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.61 - $4.49 $832,441 - $1.43 Million	318,943 New	318,943 $905,000
Q2 2023 Aug 11, 2023	SELL	$1.9 - $4.3 $647,273 - $1.46 Million	-340,670 Reduced 95.21%	17,126 $56,000
Q1 2023 May 12, 2023	BUY	$1.89 - $2.93 $676,234 - $1.05 Million	357,796 New	357,796 $762,000
Q3 2022 Nov 14, 2022	BUY	$3.14 - $6.43 $208,596 - $427,157	66,432 Added 106.01%	129,098 $418,000
Q2 2022 Aug 12, 2022	BUY	$4.74 - $8.15 $25,069 - $43,105	5,289 Added 9.22%	62,666 $305,000
Q1 2022 May 16, 2022	BUY	$6.47 - $9.57 $371,229 - $549,097	57,377 New	57,377 $437,000
Q2 2021 Aug 16, 2021	SELL	$14.92 - $23.23 $533,554 - $830,728	-35,761 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$7.33 - $21.06 $262,128 - $753,126	35,761 New	35,761 $651,000
Q4 2020 Feb 16, 2021	SELL	$3.63 - $7.53 $103,763 - $215,245	-28,585 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.29 - $4.58 $94,044 - $130,919	28,585 New	28,585 $109,000

120

62.3M

28.8K

27.9K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $378M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.